LaRDR at BLOOD conference 2024!

LaRDR showcased our research output in BLOOD poster presentations. We had four poster presentations on analyses conducted on behalf of the LaRDR investigators.

• Dr Dawn Swan (on behalf of Dr Elizabeth Smyth) presented on management practices and outcomes of high risk diffuse large B-cell lymphoma in young patients.
• Dr Luke Wang presented a literature review on the definition and use of bulk disease in phase 3 lymphoma trials.
• Ms Eliza Chung (on behalf of Dr Nicholas Viiala) presented on platinum substitution in salvage chemotherapy for relapsed/refractory non-Hodgkin lymphoma.
• Ms Eliza Chung also presented the distribution and use of bulky disease in lymphoma care.

LaRDR project manager, Ms Eliza Chung, also represented the registry at the Monash University stand 97 at the exhibition hall throughout the conference to meet and chat with other conference delegates.